PhaseBio Pharmaceuticals Inc
PHASDelisted Dec 21, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001169245
PhaseBio Pharmaceuticals Inc was delisted on Dec 21, 2022; its insiders filed their last Form 4 on May 19, 2023; 39 institutions reported holding it in 13F filings for Q3 2022, worth $3.90M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in PhaseBio Pharmaceuticals Inc as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 62
- +7 vs. Q2 2021
- Shares held
- 30.8M
- +2.00M (+6.9%) vs. Q2 2021
- Total value
- $95.9M
- −$11.4M (−10.6%) vs. Q2 2021
- New holders
- 13
- 23 more added
- Sold out
- 6
- 15 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PHAS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 5 | $15.6K |
| Q3 2022 | 39 | $3.90M |
| Q2 2022 | 50 | $14.1M |
| Q1 2022 | 57 | $38.8M |
| Q4 2021 | 52 | $73.5M |
| Q3 2021 | 62 | $95.9M |
| Q2 2021 | 56 | $113.3M |
| Q1 2021 | 62 | $110.3M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding PhaseBio Pharmaceuticals Inc; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 17 | $0 | 0.00% | −76,589−100.0% | Reduced |
| O'Shaughnessy Asset Management, LLC | 2 | $0 | 0.00% | −120−98.4% | Reduced |
| Simplex Trading, LLC | 417 | $1.00K | 0.00% | −100−19.3% | Reduced |
| Kistler-Tiffany Companies, LLC | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| Point72 Hong Kong Ltd | 164 | $1.00K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 316 | $1.00K | 0.00% | +316 | New |
| BNP Paribas Arbitrage, SA | 380 | $1.18K | 0.00% | +79+26.2% | Added |
| UBS Group AG | 1,000 | $3.00K | 0.00% | −3,087−75.5% | Reduced |
| Cutler Group LP | 1,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1,700 | $5.00K | 0.00% | +500+41.7% | Added |
| Royal Bank of Canada | 2,000 | $6.00K | 0.00% | −956−32.3% | Reduced |
| Capital Advisory Group Advisory Services, LLC | 2,800 | $9.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 3,825 | $12.0K | 0.00% | +1,000+35.4% | Added |
| Bank of America Corp | 5,496 | $17.0K | 0.00% | −1,569−22.2% | Reduced |
| Tower Research Capital LLC (TRC) | 8,122 | $26.0K | 0.00% | +4,557+127.8% | Added |
| Wells Fargo & Company | 10,597 | $33.0K | 0.00% | +8,793+487.4% | Added |
| Ergoteles LLC | 10,881 | $34.0K | 0.00% | −58,919−84.4% | Reduced |
| XTX Topco Ltd | 11,215 | $35.0K | 0.01% | +11,215 | New |
| Acadian Asset Management LLC | 12,550 | $39.0K | 0.00% | +12,550 | New |
| Cubist Systematic Strategies, LLC | 13,137 | $41.0K | 0.00% | −5,995−31.3% | Reduced |
| Citadel Advisors LLC | 13,907 | $43.0K | 0.00% | −26,477−65.6% | Reduced |
| ETF Managers Group, LLC | 17,172 | $54.0K | 0.00% | +2,993+21.1% | Added |
| Blair William & Co | 18,000 | $56.0K | 0.00% | +1,000+5.9% | Added |
| Snowden Capital Advisors LLC | 21,000 | $65.3K | 0.00% | +1,000+5.0% | Added |
| Squarepoint Ops LLC | 27,083 | $84.0K | 0.00% | +6,216+29.8% | Added |
| HRT Financial LP | 28,286 | $87.0K | 0.00% | +28,286 | New |
| Pura Vida Investments, LLC | 27,944 | $87.0K | 0.01% | +27,944 | New |
| Occudo Quantitative Strategies LP | 29,448 | $92.0K | 0.01% | +14,533+97.4% | Added |
| Goldman Sachs Group Inc | 30,616 | $95.0K | 0.00% | −20,681−40.3% | Reduced |
| Jacobs Levy Equity Management, Inc | 31,324 | $97.0K | 0.00% | +31,324 | New |
| Barclays PLC | 32,623 | $101.0K | 0.00% | −1,147−3.4% | Reduced |
| Hamilton Lane Advisors LLC | 34,208 | $106.0K | 0.02% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 40,727 | $127.0K | 0.01% | +163+0.4% | Added |
| Jump Financial, LLC | 43,867 | $136.0K | 0.01% | +43,867 | New |
| Northern Trust Corp | 62,706 | $195.0K | 0.00% | −1,775−2.8% | Reduced |
| D. E. Shaw & Co., Inc. | 78,547 | $244.0K | 0.00% | +60,873+344.4% | Added |
| State Street Corp | 79,078 | $246.0K | 0.00% | 00.0% | Unchanged |
| Resources Investment Advisors, LLC. | 88,150 | $274.0K | 0.01% | +35,700+68.1% | Added |
| Renaissance Technologies LLC | 100,566 | $313.0K | 0.00% | +100,566 | New |
| Morgan Stanley | 149,162 | $464.0K | 0.00% | +20,081+15.6% | Added |
| OrbiMed Advisors LLC | 177,113 | $551.0K | 0.01% | +177,113 | New |
| Susquehanna International Group, LLP | 180,359 | $561.0K | 0.00% | +123,075+214.9% | Added |
| Bridgeway Capital Management, LLC | 205,600 | $639.0K | 0.01% | +117,000+132.1% | Added |
| Marshall Wace, LLP | 218,877 | $681.0K | 0.00% | +218,877 | New |
| Platform Technology Partners | 229,223 | $713.0K | 0.32% | −150−0.1% | Reduced |
| Caas Capital Management LP | 263,172 | $818.0K | 0.06% | +263,172 | New |
| Geode Capital Management, LLC | 280,589 | $872.0K | 0.00% | +84,729+43.3% | Added |
| Stifel Financial Corp | 292,840 | $911.0K | 0.00% | +30,147+11.5% | Added |
| Millennium Management LLC | 299,816 | $932.0K | 0.00% | +92,273+44.5% | Added |
| Eversept Partners, LP | 300,000 | $933.0K | 0.07% | +300,000 | New |
| BlackRock Inc. | 519,359 | $1.61M | 0.00% | +32,335+6.6% | Added |
| DAFNA Capital Management LLC | 603,042 | $1.88M | 0.50% | 00.0% | Unchanged |
| Altium Capital Management LP | 775,000 | $2.41M | 0.64% | 00.0% | Unchanged |
| Candriam Luxembourg S.C.A. | 1,081,258 | $3.36M | 0.02% | +461,824+74.6% | Added |
| Endurant Capital Management LP | 1,132,523 | $3.52M | 1.07% | −997,186−46.8% | Reduced |
| Johnson & Johnson | 1,607,044 | $5.00M | 0.44% | +1,607,044 | New |
| Rock Springs Capital Management LP | 1,843,764 | $5.73M | 0.12% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,874,573 | $5.83M | 0.00% | +5,909+0.3% | Added |
| Ra Capital Management, L.P. | 2,850,000 | $8.86M | 0.12% | 00.0% | Unchanged |
| Wellington Management Group LLP | 4,024,658 | $12.5M | 0.00% | −515,239−11.3% | Reduced |
| Avidity Partners Management LP | 4,405,000 | $13.7M | 0.35% | +90,000+2.1% | Added |
| NEA Management Company, LLC | 6,643,704 | $20.7M | 0.26% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −186,031−100.0% | Sold out |
| Tibra Equities Europe Ltd | 0 | $0 | 0.00% | −91,200−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −17,190−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −10,254−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −521−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Johnson & Johnson Innovation - JJDC, Inc. | – | – | – | – | Not filed |